Latest Breaking News On - Aeon biopharma inc - Page 1 : comparemela.com

Aeon Biopharma to Slash Workforce in Half - Orange County Business Journal

Aeon Biopharma announces today that it's cutting its workforce in half after the failure of its migraine research.

Jennifer syPeter reynoldsAeon biopharma incAeon biopharmaChief executive marc forth

Aeon s Migraine: Stock Plummets as Drug Test Fails - Orange County Business Journal

Aeon Biopharma Inc.’s stock plunged 53% in intraday trading May 3 on the company’s announcement of disappointing results from testing of its migraine drug. The Irvine-based clinical-stage company (NYSE: AEON) said its ABP-450 treatment for the prevention of chronic migraine did no better than placebo in a Phase 2 trial.

Robert grantAllergan botoxNewport evolus incDrug administrationAeon biopharma incDaewoong pharmaceutical coAeon biopharmaNewport beach based alphaeonSouth korean basedNewport beach based evolus inc

AEON Biopharma (AEON) Reports Prelim Top-Line Results from Phase 2 Analysis of ABP-450

AEON Biopharma (AEON) Reports Prelim Top-Line Results from Phase 2 Analysis of ABP-450
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCorey davisAeon biopharma incDrug administrationEuropean medicines agencyEuropean unionWhile the companyExchange commissionHealth canadaMarc forthChief executive officerGood manufacturing practiceNote regarding forward lookingSci advisors

AEON Biopharma (NASDAQ:AEON) Shares Up 7 7%

AEON Biopharma (NASDAQ:AEON) Shares Up 7 7%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Formidable asset managementAeon biopharma incVanguard group incNorthern trust corpBiopharma incGet free reportTrust corpAsset managementAtalaya capital management

AEON Biopharma (AEON) Reports Topline Results from Phase 2 Trial of ABP-450

AEON Biopharma (AEON) Reports Topline Results from Phase 2 Trial of ABP-450
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCorey davisHealth canadaDrug administrationEuropean medicines agencyAeon biopharma incYork stock exchange americanExchange commissionEuropean unionPatient global impressionChief medical officerMarc forthChief executiveMonthly migraine daysRates statistically